NewGenIvf Group Limited reported a net loss attributable to shareholders of $8.04 million for the six months ended June 30, 2026, compared to a net profit of $725,000 in the same period last year. The loss was driven by a $3.42 million one-off expense from a repurchase and forbearance agreement with JAK Opportunities VI LLC and increased interest expenses totaling $541,133. Revenue slightly declined to $1.92 million from $2.02 million, but gross profit margin improved significantly to 24.1% from 15.5%, primarily due to a business model shift in Kyrgyzstan from IVF clinic operations to fertility referral services. The company also raised $2.13 million through the issuance of convertible notes during the period and completed strategic investments, including acquiring up to 10% equity interest in PredicXion Group Limited at a pre-money valuation of $100 million. NewGenIvf operates in the fertility treatment industry, providing IVF services and referral networks across multiple countries.
